MaxCyte, Inc.

US$1.26As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MXCTHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (38.95%)
Div yield —
ROE (20.39%)
Medical Devices
Beta (5Y) 1.48
PE TTM —
TSR TTM (18.18%)
Mkt cap US$130.0M
ROIC (11.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.30
3.19%
(89.00%)
Hold 7|3|11|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
3.13%
4.71%
11.88%
(0.67%)
Revenue$M
7.552
7.839
8.279
8.437
(1.19%)
5.59%
13.23%
17.16%
Peers (US$130.0M)
Cap (US$)
PE
121.9M
—
128.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.894
0.174
0.151
EBIT/Intx
0.576
0.657
0.541
Own earn%
179.82
14.44
11.17
Sh yield%
38.97
22.24
21.08
Owners
Insiders/Inst%
2.35
21.74
Short interest%
1.51
SBC / revenue%
2.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
10–16
$1 testx
0.0
Incr. ROIC%
4